Hidden warning signs of serious health issues like diabetes and high blood pressure could be lying undetected in your eyes. However, a pioneering test now available at Boots might offer individuals a ...
For instance, Novartis reported encouraging interim data in January 2024 from the Phase 3 THALES trial, which assessed crizanlizumab (SEG101) for the avoidance of vaso-occlusive crises (VOCs) in ...